SCHEMBL7989707

SCHEMBL7989707

COCC(C)(C)CC/C=C/c1cc(C)ccc1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.38
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 4/20 0.35
CYP3A4 P08684 1/20 0.35
CYP1A1 P04798 2/20 0.34
CYP1B1 Q16678 2/20 0.34
CYP1A2 P05177 1/20 0.34
NFE2L2 Q16236 1/20 0.34
KDM4E B2RXH2 2/20 0.33
L3MBTL4 Q8NA19 1/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
BACE1 P56817 1/20 0.33
PDE5A O76074 1/20 0.33
USP2 O75604 2/20 0.32
HPGD P15428 2/20 0.32
JUN P05412 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7999209 0.92 PDE5A (0.39) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL8003302 0.86 ACHE (0.40) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL13845921 0.85 CYP1A1 (0.33) KMT2AMAPTALDH1A1CYP1A1CYP1B1
SCHEMBL8002469 0.83 ACHE (0.40) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL8000126 0.80 ACHE (0.44) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL7991057 0.78 PDE5A (0.40) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL7990211 0.77 PDE5A (0.37) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL7990539 0.77 L3MBTL4 (0.42) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL8001694 0.77 L3MBTL4 (0.42) ACHEKMT2AMEN1MAPTLMNA
SCHEMBL7990252 0.77 ACHE (0.42) ACHEKMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed